Dr. James Bianco, Board Member of The Friends and CEO of the Seattle-based biotech firm, Cell Therapeutics, Inc. was recently selected CEO of the Year by the Washington CEO magazine. Under his leadership CTI was granted approval to market TRISENOX, the company’s first commercial product. The company conducts research and development of promising new products for the treatment of many malignant diseases.

Dr. Bianco, a long time opera fan, was the attending physician part of the time during José Carreras’s transplant in Seattle. His interests in opera and medical research made him an ideal member of Mr. Carreras’s foundation team.